128 related articles for article (PubMed ID: 7564877)
1. Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.
Wang GJ; Volkow ND; Fowler JS; Ding YS; Logan J; Gatley SJ; MacGregor RR; Wolf AP
Life Sci; 1995; 57(14):PL187-91. PubMed ID: 7564877
[TBL] [Abstract][Full Text] [Related]
2. A new PET ligand for the dopamine transporter: studies in the human brain.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
[TBL] [Abstract][Full Text] [Related]
3. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Dewey SL; Hitzemann R; Gifford AN; Pappas NR
J Pharmacol Exp Ther; 1999 Jan; 288(1):14-20. PubMed ID: 9862747
[TBL] [Abstract][Full Text] [Related]
4. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.
Fowler JS; Volkow ND; Logan J; Gatley SJ; Pappas N; King P; Ding YS; Wang GJ
Synapse; 1998 Feb; 28(2):111-6. PubMed ID: 9450511
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporters decrease with age.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Hitzemann R; Smith G; Fields SD; Gur R
J Nucl Med; 1996 Apr; 37(4):554-9. PubMed ID: 8691238
[TBL] [Abstract][Full Text] [Related]
7. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.
Ding YS; Fowler JS; Volkow ND; Logan J; Gatley SJ; Sugano Y
J Nucl Med; 1995 Dec; 36(12):2298-305. PubMed ID: 8523123
[TBL] [Abstract][Full Text] [Related]
8. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
9. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.
Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS
Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201
[TBL] [Abstract][Full Text] [Related]
10. [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.
Fowler JS; Volkow ND; Wang GJ; Gatley SJ; Logan J
Nucl Med Biol; 2001 Jul; 28(5):561-72. PubMed ID: 11516700
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881
[No Abstract] [Full Text] [Related]
12. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
[TBL] [Abstract][Full Text] [Related]
13. Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET.
Logan J; Volkow ND; Fowler JS; Wang GJ; Fischman MW; Foltin RW; Abumrad NN; Vitkun S; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Synapse; 1997 Dec; 27(4):347-56. PubMed ID: 9372557
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
15. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
Kilbourn MR; Sherman PS; Kuszpit K
Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
[TBL] [Abstract][Full Text] [Related]
17. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Ding YS; Logan J; Dewey SL; Hitzemann R; Lieberman J
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10388-92. PubMed ID: 8816810
[TBL] [Abstract][Full Text] [Related]
18. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
[TBL] [Abstract][Full Text] [Related]
19. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
Volkow ND; Fowler JS; Wang GJ
J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
